SafeScript – real-time prescription monitoring
SafeScript is a clinical decision support system that enables prescribers and pharmacists to access an up-to-the-minute medicines supply history of certain high-risk medicines for their patient at the point of consultation.
It is mandatory to check SafeScript prior to writing or dispensing a prescription for a high-risk medicine since April 2020. There will be exceptions in some circumstances, including when treating patients in hospitals, prisons, police jails, aged care and palliative care.
The SafeScript system is accompanied by a range of initiatives to support and prepare patients and health professionals for the implementation of SafeScript. This includes:
- A public awareness campaign to inform the general public of SafeScript and to improve the understanding of the risks associated with some prescription medicines
- Training for prescribers and pharmacists, on how to more safely prescribe and dispense high-risk medications and respond to the needs of patients.
SafeScript Training Hub
A SafeScript Training Hub is available - 'one-stop' online hub - for SafeScript. The SafeScript Training Hub includes information about the SafeScript system, training, technical support and an extensive list of resources.
Online CPD-accredited training on SafeScript is available here via the SafeScript Training Hub.
SEMPHN hosted six SafeScript training sessions for prescribers and pharmacists in 2019, and promoted two additional sessions in 2020.
DHHS SafeScript Website
For further information on SafeScript, including access to technical and non-technical support, visit the Department of Health and Human Services (DHHS) SafeScript website.
The SafeScript system itself can be accessed here by prescribers and pharmacists. However, a quicker and easier way is to set-up SafeScript integration, which is available for all the commonly used clinical software. Our Health VitalIT website provides instructions on how to set-up SafeScript integration within your clinical software for easier access for clinicians.
A document answering practice managers' most frequently asked questions regarding SafeScript is available here.
There is a General Practitioner Clinical Advisory Service (GPCAS) that assists GPs with patient issues relating to high-risk prescription medications.
GPCAS is a peer to peer advice and mentoring service.
GPCAS Clinical Advisors are GPs who have completed a comprehensive program in the management of pain, anxiety, insomnia and associated addiction and receive ongoing supervision and peer reviews by addiction medicine, addiction psychiatry and pain medicine specialists.
To use GPCAS call the Drug and Alcohol and Clinical Advisory Service (DACAS) on 1800 812 804 and ask to be referred to a GPCAS Clinical Advisor in your local area.
Within two (2) business days a SafeScript GPCAS Clinical Advisor will be in contact with you to provide advice.
Managing opioid dependence
The Area 4 Pharmacotherapy Network offers free support to prescribers and pharmacists, including advice and guidance from addiction medicine specialists, GP mentors and experienced pharmacists.
More information about this initiative is available here.
Alcohol and Other Drugs
South Eastern Melbourne PHN acknowledges the traditional custodians of the land our catchment covers, the Boon Wurrung and Wurundjeri people. We pay respect to them, their culture and their Elders past, present and future, and uphold their relationship to this land.
While the Australian Government Department of Health has contributed to the funding of this website, the information on this website does not necessarily reflect the views of the Australian Government and is not advice that is provided, or information that is endorsed, by the Australian Government. The Australian Government is not responsible in negligence or otherwise for any injury, loss or damage however arising from the use of or reliance on the information provided on this website.